New IV drug NAV-240 aims to calm painful skin bumps in hidradenitis suppurativa
Disease control
Recruiting now
This study tests whether NAV-240, given as an IV infusion, works better than a placebo for adults with moderate-to-severe hidradenitis suppurativa (HS). HS causes painful, inflamed bumps and tunnels under the skin. The main goal is to see if NAV-240 can reduce these bumps by at l…
Phase: PHASE2 • Sponsor: Navigator Medicines, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC